newsfilter
← Latest News
GlobeNewswire·

Amryt Receives Complete Response Letter from the FDA for Oleogel-S10 NDA

Amryt Receives Complete Response Letter from the FDA for Oleogel-S10 NDA DUBLIN, Ireland, and Boston, MA, February 28, 2022, Amryt (NASDAQ:AMYT), a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializi